EBV-NK cells interactions and lymphoproliferative disorders
- PMID: 9643562
- DOI: 10.3109/10428199809050908
EBV-NK cells interactions and lymphoproliferative disorders
Abstract
Epstein-Barr virus (EBV) usually infects epithelial cells in the oropharynx and B lymphocytes asymptomatically. Occasionally, however, EBV infects T-cells and natural killer (NK) cells, and infection of these cells has been associated with the development of leukemias and lymphomas. EBV-positive lymphoproliferative disorders of NK cells have been reported with increasing frequency, but the interactions between EBV and NK cells are not fully understood, in part because NK cells are not usually infected with EBV in vitro. The lymphoma-derived EBV-positive NK cell line, YT, has been useful in the study of EBV infection of NK cells. YT cells express the EBV-associated nuclear antigen (EBNA)-1, the latent membrane protein (LMP)-1, and LMP-2A, but not EBNA-2 and LMP-2B genes. This pattern of latent gene expression is compatible with a type II latency program, normally associated with nasopharyngeal carcinoma, Hodgkin's disease, and T-cell lymphoma. In this report, we summarize recent information on EBV-NK cell interactions and EBV-positive lymphoproliferative disorders of NK cells.
Similar articles
-
Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.Blood. 1998 Aug 15;92(4):1374-83. Blood. 1998. PMID: 9694726
-
Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.Int J Cancer. 1996 Nov 4;68(3):285-90. doi: 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y. Int J Cancer. 1996. PMID: 8903467
-
IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.Blood. 2006 Apr 1;107(7):2928-35. doi: 10.1182/blood-2005-06-2569. Epub 2005 Dec 6. Blood. 2006. PMID: 16332968
-
Lymphoproliferative disorders of natural killer cells.Int J Hematol. 1996 Jun;63(4):279-90. doi: 10.1016/0925-5710(96)00450-1. Int J Hematol. 1996. PMID: 8762811 Review.
-
EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.Leuk Lymphoma. 1994 Sep;15(1-2):9-16. doi: 10.3109/10428199409051672. Leuk Lymphoma. 1994. PMID: 7858507 Review.
Cited by
-
Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.Jpn J Cancer Res. 2002 Nov;93(11):1270-7. doi: 10.1111/j.1349-7006.2002.tb01234.x. Jpn J Cancer Res. 2002. PMID: 12460470 Free PMC article.
-
Maintenance and characterization of an Epstein Barr virus-infected CD56-negative T cell lymphoma.Jpn J Cancer Res. 2002 Jan;93(1):61-9. doi: 10.1111/j.1349-7006.2002.tb01201.x. Jpn J Cancer Res. 2002. PMID: 11802809 Free PMC article.
-
Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.Cancer. 2020 Jan 1;126(1):121-130. doi: 10.1002/cncr.32517. Epub 2019 Sep 16. Cancer. 2020. PMID: 31524955 Free PMC article.
-
Acute lymphocytic crisis following herpes simplex type 1 virus hepatitis in a nonimmunocompromised man: a case report.J Med Case Rep. 2009 Aug 3;3:7492. doi: 10.4076/1752-1947-3-7492. J Med Case Rep. 2009. PMID: 19830209 Free PMC article.
-
Aggressive NK Cell Leukemia: Current State of the Art.Cancers (Basel). 2020 Oct 9;12(10):2900. doi: 10.3390/cancers12102900. Cancers (Basel). 2020. PMID: 33050313 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
